Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19

CEO Albert Bourla says the gene-based technology the company learned in its partnership with Germany’s BioNTech will be applied to other diseases.

No Preview
Supreme Court Ruling on Affordable Care Act Emboldens Democrats

In courts and Congress, Republicans face a difficult path to repeal...

Capital Gains: A Century-Old Tax Break Gets a Rush of Attention

The Biden administration wants to raise tax rates on investment profits...

CVS and Walgreens Were Reeling From Pandemic, but Fortunes Have Changed

The drugstore chains say business generated by Covid-19 vaccinations is helping...

BOJ Introduces Lending Facility for Climate Change

The Japanese central bank also extended its special lending program for...